ONT vs. HEMO, BTG, ABC, GNS, ERGO, SLN, OXB, PRTC, HZD, and VRP
Should you be buying Oxford Nanopore Technologies stock or one of its competitors? The main competitors of Oxford Nanopore Technologies include Hemogenyx Pharmaceuticals (HEMO), BTG (BTG), Abcam (ABC), Genus (GNS), Ergomed (ERGO), Silence Therapeutics (SLN), Oxford Biomedica (OXB), PureTech Health (PRTC), Horizon Discovery Group plc (HZD.L) (HZD), and Verona Pharma plc (VRP.L) (VRP). These companies are all part of the "biotechnology" industry.
Oxford Nanopore Technologies vs.
Oxford Nanopore Technologies (LON:ONT) and Hemogenyx Pharmaceuticals (LON:HEMO) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings.
Hemogenyx Pharmaceuticals received 22 more outperform votes than Oxford Nanopore Technologies when rated by MarketBeat users. However, 100.00% of users gave Oxford Nanopore Technologies an outperform vote while only 57.89% of users gave Hemogenyx Pharmaceuticals an outperform vote.
38.4% of Oxford Nanopore Technologies shares are held by institutional investors. Comparatively, 0.8% of Hemogenyx Pharmaceuticals shares are held by institutional investors. 32.6% of Oxford Nanopore Technologies shares are held by insiders. Comparatively, 10.7% of Hemogenyx Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Hemogenyx Pharmaceuticals has a net margin of 0.00% compared to Oxford Nanopore Technologies' net margin of -94.82%. Oxford Nanopore Technologies' return on equity of -26.08% beat Hemogenyx Pharmaceuticals' return on equity.
Oxford Nanopore Technologies presently has a consensus target price of GBX 235.50, suggesting a potential upside of 63.75%. Given Oxford Nanopore Technologies' stronger consensus rating and higher probable upside, equities analysts plainly believe Oxford Nanopore Technologies is more favorable than Hemogenyx Pharmaceuticals.
Hemogenyx Pharmaceuticals has lower revenue, but higher earnings than Oxford Nanopore Technologies. Hemogenyx Pharmaceuticals is trading at a lower price-to-earnings ratio than Oxford Nanopore Technologies, indicating that it is currently the more affordable of the two stocks.
Oxford Nanopore Technologies has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500. Comparatively, Hemogenyx Pharmaceuticals has a beta of 3.14, suggesting that its share price is 214% more volatile than the S&P 500.
In the previous week, Oxford Nanopore Technologies had 7 more articles in the media than Hemogenyx Pharmaceuticals. MarketBeat recorded 7 mentions for Oxford Nanopore Technologies and 0 mentions for Hemogenyx Pharmaceuticals. Oxford Nanopore Technologies' average media sentiment score of 0.66 beat Hemogenyx Pharmaceuticals' score of 0.00 indicating that Oxford Nanopore Technologies is being referred to more favorably in the media.
Summary
Oxford Nanopore Technologies beats Hemogenyx Pharmaceuticals on 12 of the 17 factors compared between the two stocks.
Get Oxford Nanopore Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for ONT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Oxford Nanopore Technologies Competitors List
Related Companies and Tools
This page (LON:ONT) was last updated on 1/18/2025 by MarketBeat.com Staff
Free ONT Stock Alerts